Roshanimrr · Newsroom
New Released Report: Mauritania Tevet Project Panorama - Oil and Gas Upstream Analysis Report
"The Report Mauritania Tevet Project Panorama - Oil and Gas Upstream Analysis Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 30, 2015
Report Overview: Mozambique Upstream Fiscal and Regulatory Report
The Report Mozambique Upstream Fiscal and Regulatory Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
March 30, 2015
United Kingdom Upstream Fiscal and Regulatory Report -Size & Share
"The Report United Kingdom Upstream Fiscal and Regulatory Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 30, 2015
Industrial Report: Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 27, 2015
Report Overview : Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 27, 2015
Mavrilimumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints .
March 27, 2015
Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 27, 2015
Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 25, 2015
Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023-Competitive Landscape
"The Report Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 25, 2015
Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 25, 2015
Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 25, 2015
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints.
March 24, 2015
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 24, 2015
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 24, 2015
Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
"The Report Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
March 24, 2015
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints
March 20, 2015
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints.
March 20, 2015
PharmaPoint: Macular Edema and Degeneration - Japan Drug Forecast and Market Analysis to 2023
Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss.
March 20, 2015
Cystinosis Global Clinical Trials Review, H1, 2015
"The Report Cystinosis Global Clinical Trials Review, H1, 2015 provides
information on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
DescriptionMarch 19, 2015
Glomerulonephritis Global Clinical Trials Review, H1, 2015
"The Report Glomerulonephritis Global Clinical Trials Review, H1, 2015 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"March 19, 2015